Marco Argenti
Karyn Temple
Margaret Tempero
Marco Argenti and Karyn Temple were named to the board of the Pancreatic Cancer Action Network.
Don’t try to convince Col. Susan Fondy that lymphedema doesn’t merit interest from medical researchers.
Marco Argenti, Karyn Temple named to PanCAN board; Margaret Tempero named chair of Scientific and Medical Advisory Board
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
We recently had the privilege of contributing to a CBS Sunday Morning story on the ongoing crisis in the federal support for research in general and cancer research in particular.
Source: NIH vigil organizerSince early May, a group of current and former NIH employees have gathered every Saturday at the Medical Center Metro station in Bethesda, MD, to mourn what they describe as the loss of scientific progress under the Trump administration.
The landscape of cancer care in America faces critical challenges: geographic disparities in access, socioeconomic barriers to advanced treatments and the increasing complexity of precision medicine that outpaces individual providers’ ability to stay current. At City of Hope, we are addressing these systemic issues through a bold expansion that brings world-class cancer care and research closer to where patients live.
When the Women’s Health Initiative was announced in 1991, it was set to be the largest women’s health study ever conducted. The WHI scope is massive: the initiative has recruited more than 161,000 women and engaged more than 5,000 scientists from the U.S. and beyond.
The U.S. House of Representatives Thursday passed President Trump’s “One Big Beautiful Bill,” a sweeping legislation that makes the biggest cuts to Medicaid since the program began in the 1960s.
